Expertise in
8
conditions

Dr. Amir Kamran

Hematology
CAMC Cancer Center
3415 Maccorkle Ave SE, 
Charleston, WV 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
8
conditions
CAMC Cancer Center
3415 Maccorkle Ave SE, 
Charleston, WV 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Amir Kamran is a Hematologist in Charleston, West Virginia. Dr. Kamran is highly rated in 8 conditions, according to our data. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, Renal Cell Carcinoma (RCC), and Chromophobe Renal Cell Carcinoma.

His clinical research consists of co-authoring 24 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology
Licenses
Internal Medicine in WV
Hospital Affiliations
Charleston Area Medical Center
Boone Memorial Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Dominion National
  • MEDICARE PDP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

CAMC Cancer Center
3415 Maccorkle Ave SE, Charleston, WV 25304

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
Enrollment Status: Recruiting
Publish Date: February 04, 2026
Intervention Type: Procedure, Other
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Enrollment Status: Recruiting
Publish Date: September 11, 2025
Intervention Type: Procedure, Drug, Other, Radiation
Study Drugs: Abiraterone, Bicalutamide, Degarelix, Docetaxel, Flutamide, Goserelin acetate, Histrelin acetate, Leuprolide acetate, Nilutamide, Prednisone, Triptorelin
Study Phase: Phase 3
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Cabozantinib, Ipilimumab, Nivolumab
Study Phase: Phase 3
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2025
Intervention Type: Biological, Drug, Radiation
Study Drugs: Gonadotrophin releasing hormone, Niraparib
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

23 Total Publications

Comparative efficacy of osimertinib with and without radiation therapy in EGFR-mutated nonsmall cell lung cancer with brain metastases.
Comparative efficacy of osimertinib with and without radiation therapy in EGFR-mutated nonsmall cell lung cancer with brain metastases.
Journal: Seminars in oncology
Published: July 25, 2025
Similar Doctors
Expertise in
55
conditions
Dr. Narender Jogenpally
Hematology
Expertise in
55
conditions
Dr. Narender Jogenpally
Hematology

Arvind B Shah MD Inc

401 Division St Ste 100, 
South Charleston, WV 
 (8.2 miles away)
304-766-4350
Languages Spoken:
English
See accepted insurances

Narender Jogenpally is a Hematologist in South Charleston, West Virginia. Dr. Jogenpally is highly rated in 55 conditions, according to our data. His top areas of expertise are Familial Colorectal Cancer, Inflammatory Breast Cancer, Colorectal Cancer, Angiosarcoma, and Bone Marrow Aspiration.

Expertise in
24
conditions
Dr. John Ponugupati
Hematology
Expertise in
24
conditions
Dr. John Ponugupati
Hematology

Arvind B Shah MD Inc

401 Division St Ste 100, 
South Charleston, WV 
 (8.2 miles away)
304-766-4350
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Ponugupati is a Hematologist in South Charleston, West Virginia. Dr. Ponugupati is highly rated in 24 conditions, according to our data. His top areas of expertise are Childhood Iron Deficiency Anemia, Colorectal Cancer, Familial Colorectal Cancer, Iron Deficiency Anemia, and Bone Marrow Aspiration.

Expertise in
43
conditions
Dr. Muhammad Jamil
Hematology
Expertise in
43
conditions
Dr. Muhammad Jamil
Hematology

Edwards Cancer Center

1400 Hal Greer Blvd, 
Huntington, WV 
 (45.2 miles away)
304-399-6515
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Muhammad Jamil is a Hematologist in Huntington, West Virginia. Dr. Jamil is highly rated in 43 conditions, according to our data. His top areas of expertise are Lung Cancer, Thymic Epithelial Tumor, Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kamran's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 53 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile